OM:CRNO BBiotechs
Cereno Scientific (OM:CRNO B) Q1 Loss Of SEK 28.6m Keeps Cash Burn Concerns In Focus
Cereno Scientific (OM:CRNO B) has opened 2026 with Q1 revenue of 38.97 million SEK and a net loss of 28.60 million SEK, setting a clear marker for how the company is progressing against its current research focused profile. Over recent quarters the company has seen revenue range between 6.18 million SEK and 16.42 million SEK across 2025, while losses over that period moved between 21.32 million SEK and 44.71 million SEK, giving investors a concrete sense of how much revenue is currently being...